08.11.2012 08:30:00

Appointment to Arkema Board of Directors

Regulatory News:

Arkema’s Board of Directors, at a meeting held on November 7th 2012, decided to propose to the next ordinary general meeting on June 4th 2013 the appointment of Mrs Victoire de Margerie as Director of Arkema.

At their meeting on November 7th 2012, the Board of Directors unanimously decided to co-opt Mrs Victoire de Margerie, principal shareholder and managing director of Rondol Technology.

Her appointment will be subject to ratification by the ordinary general meeting on June 4th 2013.

"Arkema’s Board of Directors is delighted to welcome Mrs de Margerie. Victoire de Margerie will bring to the Board the benefit of her knowledge of the chemical sector and other industrial sectors, of her international career and her experience as a director of listed companies" stated Thierry Le Hénaff, Chairman and Chief Executive Officer of Arkema at the close of the board meeting.

Victoire de Margerie has been Chairman and principal shareholder of Rondol Technology, a British micromechanics SME, since 2009. She previously held operational posts in industry in Germany, France and the United States within Elf Atochem, Carnaud MetalBox and Péchiney. Between 2002 and 2011, she also taught strategy and management of technology at the Grenoble School of Management. She serves as a director in a number of listed companies, including Norsk Hydro (aluminium), Eurazeo and Morgan Crucible (advanced materials).

Victoire de Margerie is a graduate of the Ecole des Hautes Etudes Commerciales in Paris and of the IEP in Paris, and she holds a DESS in Private Law from the Université de Paris 1 Panthéon Sorbonne, and a PhD in Management Science from the Université de Paris 2 Panthéon Assas.

A global chemical company and France’s leading chemicals producer, Arkema (Paris:AKE) is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, some 14,000 employees and 10 research centers, Arkema generates annual revenue of approximately €6.5 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu ArkemaAct.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ArkemaAct. 83,15 3,61% ArkemaAct.

Indizes in diesem Artikel

EURO STOXX 563,41 -0,90%
SBF 120 6 145,99 -0,93%